---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-087465"
form_type: "8-K"
ticker: "TOVX"
cik: "0000894158"
company_name: "Theriva Biologics, Inc."
filed_at: "2025-09-04T23:59:59+00:00"
generated_at: "2026-05-17T08:24:54.294116+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Theriva Biologics shareholders approve equity plan increase and elect directors at annual meeting

## Summary
- Shareholders approved Amendment No. 3 to increase shares under 2020 Stock Incentive Plan from 2.5M to 4.5M.
- All four director nominees elected: Jeffrey J. Kraws, Steven A. Shallcross, John Monahan, Jeffrey Wolf.
- Ratified BDO USA, P.C. as independent auditor for FY2025 with 3.61M votes for.
- Advisory vote on executive compensation approved; future frequency set at three years.
- Vote totals for each proposal are disclosed; broker non-votes totaled 2,212,112 shares.

## SEC filing metadata
- accession: 0001104659-25-087465
- form_type: 8-K
- ticker: TOVX
- cik: 0000894158
- company_name: Theriva Biologics, Inc.
- filed_at: 2025-09-04T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.02, 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/894158/000110465925087465/0001104659-25-087465-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/894158/000110465925087465/tm2525057d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-087465
- JSON: https://secwatch.observer/filing/0001104659-25-087465.json
- Plain text: https://secwatch.observer/filing/0001104659-25-087465.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.